Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
A national dementia plan for China has been officially launched as a part of China’s Action Plan for Healthy China 2030.
Alzheimer’s Disease International (ADI) launches the world’s most comprehensive report on dementia-related design and the built environment.
Dementia design in built environment is 30 years behind physical disabilities movement ADI calls on governments to embed design in their national dementia responses under the Convention on the Rights for Persons with Disabilities Dementia design follows simple principles, is cost effective and dramatically improves enjoyment and safety of built environment…
Press release on COVID-19 deaths and dementia
At the beginning of World Alzheimer's Month, ADI highlights evidence that the COVID-19 pandemic is leading to extremely high death rates amongst people with dementia globally.
The Dominican Republic’s Ministry of Public Health announces that the country will be launching a national dementia plan.
ADI's Global Perspective for July 2020 now available.
The German Government announces that a national dementia strategy has been officially adopted.